Nichols & Pratt Advisers’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Nichols & Pratt Advisers's RGEN Position: Q1 2025 in Review
Nichols & Pratt Advisers sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,505 shares — an estimated $217K sold.
Nichols & Pratt Advisers first reported a position in RGEN in Q3 2023 and held it in 6 quarters. The position peaked at $470K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Nichols & Pratt Advisers reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Nichols & Pratt Advisers sold 1,505 Repligen shares in Q1 2025, an estimated $217K.
- Nichols & Pratt Advisers first reported a position in Repligen in Q3 2023 and held it in 6 quarters.
- Nichols & Pratt Advisers's Repligen position peaked at $470K in Q1 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Nichols & Pratt Advisers's 13F filing for Q1 2025, filed 29 Apr 2025.